A review on the Scorpaena plumieri fish venom and its bioactive compounds
© The Author(s). 2016
Received: 27 July 2016
Accepted: 30 November 2016
Published: 21 December 2016
The most poisonous fish species found along the Brazilian coast is the spotted scorpionfish Scorpaena plumieri. Though hardly ever life-threatening to humans, envenomation by S. plumieri can be quite hazardous, provoking extreme pain and imposing significant socioeconomic costs, as the victims may require days to weeks to recover from their injuries. In this review we will walk the reader through the biological features that distinguish this species as well as the current epidemiological knowledge related to the envenomation and its consequences. But above all, we will discuss the challenges involved in the biochemical characterization of the S. plumieri venom and its compounds, focusing then on the successful isolation and pharmacological analysis of some of the bioactive molecules responsible for the effects observed upon envenomation as well as on experimental models. Despite the achievement of considerable progress, much remains to be done, particularly in relation to the non-proteinaceous components of the venom. Therefore, further studies are necessary in order to provide a more complete picture of the venom’s chemical composition and physiological effects. Given that fish venoms remain considerably less studied when compared to terrestrial venoms, the exploration of their full potential opens a myriad of possibilities for the development of new drug leads and tools for elucidating the complex physiological processes.
KeywordsScorpionfish Scorpaena plumieri venom Inflammatory response Proteolytic activity Cardiovascular activity Sp-GP Plumieribetin C-type lectins Sp-CTx
The Brazilian coast is home to a large variety of venomous fish species, the most poisonous being the spotted scorpionfish Scorpaena plumieri [8–11]. It is noteworthy that the Scorpaeniformes (families Scorpaenidae and Synanceiidae) are the most venomous marine fishes in the world [11, 12].
The venom gland in scorpionfishes is not a well-defined structure, but consists of a group of secretory cells lying within the spines anterolateral grooves, without an excretory duct [11, 16]. Therefore, the venom apparatus in this species comprises the spines plus the integumentary sheath associated with them. Envenomation occurs through mechanical pressure on the spines, which tears the integumentary sheath to allow the release of the venom along with the mucus present in the skin [17, 18]. This quite primitive venomous apparatus, common among poisonous fishes, has evolved mostly for defensive purposes, which is consistent with its involuntary delivery mechanism [1, 2].
Humans can become victims of S. plumieri when fishermen, divers and bathers accidentally tread on or handle the fish and have their skin perforated by the spines . The clinical manifestations of accidents include local and systemic effects. The first symptom is always excruciating pain, followed by edema, erythema, occasional skin necrosis, adenopathy, nausea, vomiting, agitation, malaise, sweating, diarrhea, tachycardia and arrhythmias, culminating, in some cases, in severe hypotension . The treatment is symptomatic and usually consists of soaking the affected limb in hot water (45–50 °C) at least until the pain is relieved, though why such heat is effective remains under discussion .
Envenomation by S. plumieri, though hardly ever life-threatening to humans, imposes considerable socioeconomic costs, given that fishermen — the group most prone to accidents — may require days to weeks to recover from their injuries . And even if accidents involving S. plumieri are — at least according to the official reports made to the Notifiable Diseases Information System (SINAN) — somewhat rare when compared to other venomous aquatic species found in Brazil, the potential severity of the injuries caused by these stings justifies the need for a thorough investigation of these cases .
The Laboratory of Protein Chemistry of the Federal University of Espírito Santo (UFES), Brazil, which has been studying the venom of S. plumieri for over a decade, is responsible for the great majority of the literature on this topic. Considerable progress has been made in relation to the biochemical and pharmacological properties of the crude venom extract [20–23] and a few bioactive molecules have been isolated and analysed [20, 24–28]. In this review, we will focus on the discussion of the chemical and physio-pharmacological properties of S. plumieri venom along with those of the bioactive molecules isolated so far.
Extraction and chemical composition of S. plumieri venom
Given that the venom gland in S. plumieri is not a well-defined structure, the collection of the venom in an uncontaminated form is technically difficult. Hence, S. plumieri venom studies have been conducted using the extract from its venomous apparatus. This venomous extract (referred to as SpV) has been obtained according to the batch method  adapted by Carrijo et al. , in which an average-sized fish (15–20 cm) yields ≈ 10–16 mg of total protein.
SpV is mucous-rich, which presents a considerable challenge to its study. Nevertheless, the major hindrance to elucidating the nature of the venom has been the instability of its active components, which could be partially due to the presence of endogenous proteolytic enzymes [20, 24].
The protein complexity of SpV is evident from a number of different components found when the extract was subjected to two-dimensional SDS-PAGE. This analysis revealed about two hundred protein spots (6 to 120 kDa) with a predominance of anionic proteins . A similar molecular weight range has been described for the protein components of other fish venoms [30–32].
In addition to the protein constituents, some other active compounds, such as biogenic amines have been described in fish venoms [33–37]. However, these components — which also present important implications for venom activity — have yet to be explored in S. plumieri venomous extract.
Biological activities of S. plumieri venom extract (Spv)
Studies conducted on SpV have shown the enormous diversity and complexity of its biological activities. SpV was found to perform lethal, hemolytic, cardiovascular, inflammatory, integrin-binding-inhibitory and proteolytic activities [20, 22–24, 27, 29]. This spectrum of activities — observed in experimental animals — resembles those of other fish venoms previously described [1, 2].
The first study focusing on biological properties of SpV was reported by Carrijo et al. . Intravenous injection of SpV in mice induced loss of muscular coordination, paralysis, urination, hypersalivation, convulsions and respiratory failure, followed by death. The LD50 was estimated to be 0.28 mg/kg, a value comparable to those reported for venoms of other scorpaeniform fish [4, 38, 39]. The venom also displays dose-dependent hemolytic activity on rabbit erythrocytes . Furthermore, as SpV lacks phospholipase A2 activity — much like other fish venoms — the hemolysis can be explained by pore formation activity .
As previously mentioned, the first and most notable effect of the envenomation is clinically characterized by intense edema, erythema and excruciating pain, which are generally associated with an inflammatory response . Experiments conducted using the mice paw test have shown that the injection of SpV into the footpad induces intense edema that is time- and dose-dependent . In contrast, a pronounced nociceptive response reaches a plateau at low doses (≥15 μg/paw) . This inflammatory response is characterized by a release of pivotal pro-inflammatory mediators (TNF, IL-6 and MCP-1) that may be associated with histopathological changes observed in paw tissue, distinguished by cellular infiltration of mainly neutrophils followed by mononuclear cells after 12 h . SpV-induced edema was found to be significantly reduced by previous administration of a serine-protease inhibitor (aprotinin) or a bradykinin B2 receptor antagonist (icatibant), while pretreatment with a non-selective COX inhibitor (diclofenac sodium) and a H1 receptor antagonist (promethazine) had less effect, suggesting that the kallikrein-kinin system (KKS) plays a major role in the edema formation .
In addition to the local inflammatory response, a systemic reaction is triggered after SpV injection in the footpad or peritoneal cavity of mice, leading to endothelial barrier dysfunction, microvascular hyperpermeability and sustained inflammatory response, culminating in alveolar edema and neutrophilic inflammation. Alveolar macrophages (AM) and neutrophils act as a source of matrix metalloproteinases that together play a key role in the cascade of events leading to lung injury. These findings also confirm a central role for macrophage and neutrophils in the pathogenesis of venom-induced lung injury and also the importance of AMs in the resolution of this SpV-triggered process .
These inflammatory responses may be due to the activity of proteases, hyaluronidases and integrin-inhibiting factors that could affect the extracellular matrix (ECM). And indeed, enzymatic activities are prominently described in the literature on fish — and terrestrial — venoms [40–43]. These enzymes initiate reactions that can contribute to local and systemic effects by acting as “spreading factors”, either increasing tissue permeability and facilitating the spread of other constituents of the venom or causing direct tissue damage to the prey . Furthermore, these enzymes are also involved in the post-translational processing of the many toxins in the venom .
SpV was shown to hydrolyse casein and gelatin . These proteolytic activities were also reported in the venoms of the fish Potamotrygon falkneri and Thalassophyne maculosa, respectively [31, 32]. Akin to most fish venoms, SpV is devoid of any phospholipase activity, albeit phospholipase C activity has been detected in the Scatophagus argus venom .
Due to their pivotal role, integrins — which are receptors of the ECM — are targets for several naturally occurring toxins. There are several literature reports of these molecules in snake venoms, including desintegrins  and C-type lectins [48–50]. On the other hand, only recently have these molecules been reported in fish venoms. A cell-free binding assay showed that SpV inhibited the binding of integrins α1β1, α2β1, α3β1 and α7β1 to their respective ligands: collagen IV, collagen I, laminin-332 and laminin-111 .
Among all the effects caused by fish venoms, cardiovascular activity has been the main subject of research in the field [1, 2]. Clinical reports have shown that the symptoms of S. plumieri envenomation include respiratory distress and tachycardia . Similarly, it was observed in animal models that SpV increases mean arterial pressure (MAP) in a dose-dependent manner. However, biphasic responses — characterized by an initial increase followed by a pronounced fall of the MAP — are achieved using higher doses (338 μg/kg), leading to the death of the animal after a few minutes . This phenomenon was also observed in other fish venoms, such as P. volitans, S. horrida and S. guttata. The high-pressure phase has been associated with adrenoceptors while the hypotensive phase seems to involve muscarinic receptors and/or nitric oxide synthesis [51, 52].
In isolated hearts, SpV produces dose-dependent and transient positive ventricular chronotropic, inotropic and lusitropic effects. These responses are attenuated by a non-selective β-adrenergic antagonist, evidencing that the venom compounds could act — at least in part — directly through the presence of some adrenergic agonist in the venom and/or indirectly via the release of endogenous stores of norepinephrine from the sympathetic varicosities in the heart .
Besides the activity on the cardiac muscle, SpV also produces vascular effects. SpV induces a dose-dependent increase in perfusion pressure (CPP) on the coronary bed, and a biphasic effect on intact and pre-contracted rat aortic rings — characterized by an initial and transient relaxing phase followed by a sustained contractile phase [22, 24]. It is noteworthy that variations in vascular responses induced by the same fish venom have been observed in studies applying different experimental models .
The unravelling of the precise action mechanism behind all the biological activities attributed to venoms depends on the isolation of the substances responsible for each one of these activities.
Finally, despite all the difficulties surrounding the purification of active proteins from fish venoms our group has isolated four proteins from SpV. In the following section we will discuss the biochemical, physiological and pharmacological features of these proteins.
Bioactive proteins isolated from Spv
Scorpaena plumieri gelatinolytic protease (Sp-GP)
The first toxin isolated from SpV was Sp-GP, a 72 kDa protease with gelatinolytic activity. In fact, to the best of our knwoledge, it was the first active protein isolated from a scorpionfish . Homogeneity was reached through three purification steps: gel filtration (Fig. 3), ion exchange, and reverse-phase chromatography. The ineffectiveness of efforts at N-terminal sequencing suggests that the enzyme is N-terminally blocked. The optimal pH value for its activity was found to be within the range of 7–8 . Although many fish venoms were found to perform proteolytic activity, the only other isolated fish venom proteases comprise a group of five toxins termed natterins (5.9–41.4 kDa) found in the venom of the toadfish Thalassophryne nattereri. These proteases cleave human kininogen and degrade type I and type IV collagen in vitro. The latter leads to direct induction of necrosis, stimulating an inflammatory response, which, in turn, correlates with the edema-inducing effects of the toxin [53, 54].
Extracts from vegetable or animal sources — venoms, for instance — have the ability to induce the agglutination of hemocytes and to disrupt cell-ECM interactions [48, 55]. These abilities are related to the activity of molecules with carbohydrate-binding properties: the lectins.
Two lectins — (i) plumieribetin, a lectin homologous to monocot mannose-binding B-type lectin and (ii) a group of five isolectins (Sp-CL 1–5) homologous to fish C-type lectins — were purified from S. plumieri venom [27, 28].
Plumieribetin was purified with a high degree of homogeneity by gel filtration chromatography — from both SpV (Fig. 3) and skin mucus — as a 14 kDa band in SDS-PAGE. Analytical gel filtration on a calibrated size exclusion column provided several peaks, most of which contained this same protein in different oligomeric states (mainly as a tetramer). Cross-linkage studies confirmed the oligomeric nature of this integrin-inhibiting factor. Plumieribetin is characterized by an abundance of anti-parallel beta strands, just as the aforementioned B-type lectins. The primary structure of plumieribetin is highly similar to those of homologous proteins isolated from other fishes, namely Platycephalus indicus (71.5%), the green puffer fish Tetraodon nigroviridis (63.7%) and the Japanese pufferfish T. rubripes (56.8%) .
Plumieribetin binds to α1β1 integrin irrespective of N-glycosilation — indicating direct protein-protein interaction — supressing α1β1 integrin binding to basement membrane collagen IV. It could not fully detach hepatocarcinoma HepG2 cells or primary arterial smooth muscle cells from collagen IV fragment CB3. It did, however, attenuate cell-collagen contacts and cell spreading, changing the actin cytoskeleton after blocking the compensating α2β1 integrin as well .
In addition to the hemagglutinating fraction (FV) (Fig. 3), five main absorbance peaks were detected by reverse phase high performance liquid chromatography (RP-HPLC) (RP1, 2, 3, 4 and 5). Mass spectrometry analysis of these fractions on matrix-assisted laser desorption/ionization — time of flight (MALDI-TOF) revealed a high degree of homogeneity with m/z signals and molecular masses of 16.981, 16.982, 16.975, 16.841 and 16.842 kDa. The amino acid sequence of RP4 revealed homology (24–32% of identity) with various fish C-type lectins. Finally, the presence of the glycan moiety galactose-β(1 → 4)-N-acetylglucosamine was also revealed in the FV structure .
The similar chemical characteristics exhibited by RP fractions (elution in RP-HPLC and MALDI-TOF) — together with the similarities found among amino acid sequences — strongly suggest that RP1-5 are C-type lectin isoforms (isolectins) .
Scorpaena plumieri cytolytictoxin (SP-Ctx)
Considerable evidence suggests that the cardiovascular, inflammatory and cytolytic effects attributed to Scorpaenidae fish venoms are due to the action of a single labile “lethal protein factor” [1, 5, 56].
A cytolysin denominated Sp-CTx — a glycoprotein with two subunits (of ≈ 65 kDa each) — was purified from the venom of S. plumieri . Next, an improved purification approach was established, which reduced the time and the number of chromatography steps needed to obtain the pure toxin . Due to the lability of Sp-CTx, such a time reduction is crucial to the success of its isolation and functional characterization.
Like other fish cytolysins, Sp-CTx has shown hemolytic activity in rabbit erythrocytes attenuated by osmotic protectants (polyethylene glycol polymers) and molecules larger than 6 nm in diameter. This strongly suggested that Sp-CTx might be a pore-forming protein, since it lacks phospholipase A2 activity . Furthermore, previous reports have shown that the hemolytic effect induced by SNTX was fully prevented by osmotic protectants of adequate size while uncharged molecules of smaller size failed to avert cell lysis . More recently, the pore formation mechanism was directly visualized through transmission electron microscopy of SNTX .
Despite its hemolytic effect, the focus of Sp-CTx research has been on its cardiovascular activities. In vivo and in vitro (isolated hearts) studies revealed that Sp-CTx reproduces the effects induced by SpV. In isolated papillary muscle, Sp-CTx produces a positive inotropic effect attenuated by propranolol and the catecholamine releasing agent tyramine, while increasing L-type Ca2+ current density in isolated ventricular cardiomyocytes. These results show that Sp-CTx induces cardiovascular disorders through an increase of sarcolemmal calcium influx, partially due to the release of endogenous noradrenaline . In addition, Sp-CTx reproduced the SpV-induced effect on aortic rings, although the relaxation phase is less marked in this case. This relaxant effect is abolished after endothelial denudation, suggesting that the release of endothelium-derived relaxing factors is involved in this response .
Besides the cytolytic and cardiovascular effects displayed by cytolysins isolated from fish venoms, other pharmacological effects such as edematogenic and nociceptive activities have been reported . As to Sp-CTx, a thorough investigation of its role in the inflammatory effect induced by SpV remains to be done.
Toxins purified from SpV to date
(subunits ≈ 65 kDa)
Hemolytic activity — cell membrane pore formation
Cardiovascular biphasic response in vivo — initial systolic and diastolic pressure increase followed by decrease
Positive inotropic effect on cardiac muscle
Increase of Ca2+ current on isolated cardiomyocytes
Vasoconstriction — coronary bed
Vasodilation — aortic ring
(monomer — 13.157 kDa)
High content of anti-parallel strands
Integrin inhibitory activity
Attenuation of cell-collagen contacts and cell spreading
Recognizes the sugar motif
(Gal-β(1 → 4)GlcNAc)
Molecular genetics of S. plumieri venom
The difficulties surrounding the study of fish venoms also affect their characterization at the molecular level. To date few reports have been published regarding the analysis of fish venoms from a genetic point of view [59–62]. Transcriptomic approaches performed on the venom glands of the stingray Neotrygon kuhlii  and the toadfish Thalassophryne nattereri  revealed a considerable number of proteins that are related to the pharmacological activity of these venoms — e.g. galectins  and C-type lectins  — as well as some that are novel to fish venoms. A preliminary analysis of expressed sequence tags (EST) obtained through a cDNA library from S. plumieri venom revealed that about 30% of the sequences had no similarities with previously described ones, suggesting the presence of unknown genes of potential relevance in the venom gland. In addition, the screening of the library with antibodies against a lectin fraction from S. plumieri venom has shown that lectin-like genes account for 12% of all transcripts, a finding confirmed by extensive in silico analysis . These constitute the very first steps towards the unraveling of the molecular diversity contained in fish venoms.
Neutralization of S. plumieri toxic activities
Although there is no antivenom available for the envenoming by S. plumieri, the commercial antivenom raised against the venom of the stonefish Synanceia trachynis (SFAV) — a horseFab’2 preparation made by CSL in Melbourne, Australia  — evoked a cross-reactive immune response to SpV.
SFAV neutralizes all known clinical effects of serious S. trachynis envenomation , and is also efficient in neutralising the inflammatory and cardiovascular responses as as well as the hemolytic activity induced by S. plumieri in mice , suggesting that the compounds responsible for these effects share similar biochemical and antigenic properties to those found in stonefish venom. This antivenom also neutralises some of the toxic effects of other stonefish (S. verrucosa), lionfish (Pterois volitans, P. lunulata, P. antennata and Dendrochirus zebra) and soldierfish (Gymnapistes marmoratus) [51, 65, 66].
This is in accordance with the hypothesis that venomous fishes belonging to different genera or inhabiting different regions may share venom compounds with similar antigenic properties .
In conclusion, despite all the progress made recently, many questions remain to be answered, not only with respect to the physio-pharmacological effects and the precise action mechanism of some of the components already described, but also as to the considerable number of molecules still unexplored in the venom of S. plumieri. The study and exploration of the full potential contained in fish venoms can contribute to a better understanding of complex physiological processes — such as the very pain induced by the envenomation — and to the discovery of new drugs, not to mention the development of more effective ways to treat the injuries caused by these animals.
Coronary perfusion pressure
Expressed sequence tags
Matrix-assisted laser desorption/ionization – time of flight
Mean arterial pressure
Reverse phase high performance liquid chromatography
Notifiable diseases information system
Scorpaena plumieri gelatinolytic protease
S. plumieri venom extract
Federal University of espírito santo
The authors would like to thank all the members of the Laboratory of Protein Chemistry for the useful insights. Thanks are also due to the Center for the Study of Venoms and Venomous Animals (CEVAP) of UNESP for enabling the publication of this paper (Edital Toxinologia CAPES no. 063/2010, Process no. 230.38.006285/2011-21, AUXPE Toxinologia 1219/2011).
This work was funded by a FAPES/CNPq grant to FVC (grant no. 012/2014), by CAPES grants to TNM, PFM and GBN, by a FAPES-Profix grant to HLG (grant no. 009/2014) and by an INCTTOX/CNPq grant (grant no. 573790/2008-6). It was also supported by the Edital Toxinologia CAPES no. 063/2010, process no. 230.038.007890/2011-10, AUXPE Toxinologia 1824/2011 (granted to SGF).
All authors contributed equally to the preparation of this manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Church JE, Hodgson WC. The pharmacological activity of fish venoms. Toxicon. 2002;40(8):1083–93.View ArticlePubMedGoogle Scholar
- Ziegman R, Alewood P. Bioactive components in fish venoms. Toxins. 2015;7(5):1497–531.View ArticlePubMedPubMed CentralGoogle Scholar
- Lopes-Ferreira M, Grund LZ, Lima C. Thalassophryne nattereri fish venom: from the envenoming to the understanding of the immune system. J Venom Anim Toxins incl Trop Dis. 2014;20:35. doi:10.1186/1678-9199-20-35.View ArticlePubMedPubMed CentralGoogle Scholar
- Schaeffer Jr RC, Carlson RW, Russell FE. Some chemical properties of the venom of the scorpionfish Scorpaena guttata. Toxicon. 1971;9(1):69–78.View ArticlePubMedGoogle Scholar
- Figueiredo SG, Andrich F, Lima C, Lopes-Ferreira M, Haddad Jr V. Venomous fish: a brief overview. In: de Lima ME, Pimenta AMC, Martin-Eauclaire MF, Zingali R, Rochat H, editors. Animal Toxins: State of the Art. Perspectives on Health and Biotechnology. Belo Horizonte: UFMG; 2009.Google Scholar
- Smith WL, Wheeler WC. Venom evolution widespread in fishes: a phylogenetic road map for the bioprospecting of piscine venoms. J Hered. 2006;97(3):206–17.View ArticlePubMedGoogle Scholar
- Nelson JS. Fishes of the World. 3rd ed. New York: Wiley; 1984.Google Scholar
- Haddad Jr V, Lupi O, Lonza JP, Tyring SK. Tropical dermatology: marine and aquatic dermatology. J Am Acad Dermatol. 2009;61(5):733–50.View ArticlePubMedGoogle Scholar
- Oliveira JS, Pires Junior OR, Morales RAV, Bloch Junior C, Schwartz CA, Freitas JC. Toxicity of puffer fish — two species (Lagocephalus laevigatus, Linaeus 1766 and Sphoeroides spengleri, Bloch 1785) from the Southeastern Brazilian coast. J Venom Anim Toxins incl Trop Dis. 2003;9(1):76–88.View ArticleGoogle Scholar
- Simões EMS, Mendes TMA, Adão A, Haddad Jr V. Poisoning after ingestion of pufferfish in Brazil: report of 11 cases. J Venom Anim Toxins incl Trop Dis. 2014;20:54. doi:10.1186/1678-9199-20-54.View ArticleGoogle Scholar
- Haddad Jr V, Martins IA, Makyama HM. Injuries caused by scorpionfishes (Scorpaena plumieri Bloch, 1789 and Scorpaena brasiliensis Cuvier, 1829) in the Southwestern Atlantic Ocean (Brazilian coast): epidemiologic, clinic and therapeutic aspects of 23 stings in humans. Toxicon. 2003;42(1):79–83.View ArticlePubMedGoogle Scholar
- Gwee MC, Gopalakrishnakone P, Yuen R, Khoo HE, Low KS. A review of stonefish venoms and toxins. Pharmacol Ther. 1994;64(3):509–28.View ArticlePubMedGoogle Scholar
- Humann P. Reef fish identification: Florida, Caribbean Bahamas. Deloach N, editor. Florida: New World Publications; 1994.Google Scholar
- Moyle PB, Cech Jr JJ. Fishes: an introduction to ichthyology. 3rd ed. USA: Prentice-Hall; 1996.Google Scholar
- Bloch 1789 apud Eschmeyer WN. A systematic review of the scorpionfishes of the Atlantic Ocean (Pisces: Scorpaenidae). California: Academy of Sciences; 1969.Google Scholar
- Russel FE. Marine toxins and venomous and poisonous marine animals. In: Russel FS, editor. Advances in Marine Biology, vol. 2. London: Academic; 1965.Google Scholar
- Halstead BW. Injurious effects from the sting of the scorpionfish, Scorpaena guttata with report of a case. Calif Med. 1951;74(5):395–6.PubMedPubMed CentralGoogle Scholar
- Roche ET, Halstead BW. Fish Bulletin of the Department of Fish and Game of State of California. 1972;156:1–49. http://content.cdlib.org/view?docId=kt8z09n9rg&brand=calisphere&doc.view=entire_text.
- Reckziegel GC, Dourado FS, Neto DG, Haddad Jr V. Injuries caused by aquatic animals in Brazil: an analysis of the data present in the information system for notifiable diseases. Rev Soc Bras Med Trop. 2015;48(4):460–7.View ArticlePubMedGoogle Scholar
- Carrijo LC, Andrich F, de Lima ME, Cordeiro MN, Richardson M, Figueiredo SG. Biological properties of the venom from the scorpionfish (Scorpaena plumieri) and purification of a gelatinolytic protease. Toxicon. 2005;45(7):843–50.View ArticlePubMedGoogle Scholar
- Boletini-Santos D, Komegae EN, Figueiredo SG, Haddad Jr V, Lopes- Ferreira M, Lima C. Systemic response induced by Scorpaena plumieri fish venom initiates acute lung injury in mice. Toxicon. 2008;51(4):585–96.View ArticlePubMedGoogle Scholar
- Gomes HL, Andrich F, Mauad H, Sampaio KN, de Lima ME, Figueiredo SG, et al. Cardiovascular effects of scorpionfish (Scorpaena plumieri) venom. Toxicon. 2010;55(2–3):580–9.View ArticlePubMedGoogle Scholar
- Menezes TN, Carnielli JB, Gomes HL, Pereira FE, Lemos EM, Bissoli NS, et al. Local inflammatory response induced by scorpionfish Scorpaena plumieri venom in mice. Toxicon. 2012;60(1):4–11.View ArticlePubMedGoogle Scholar
- Andrich F, Carnielli JB, Cassoli JS, Lautner RQ, Santos RA, Pimenta AM, et al. A potente vasoactive cytolysin isolated from Scorpaena plumieri scorpionfish venom. Toxicon. 2010;56(4):487–96.View ArticlePubMedGoogle Scholar
- Gomes HL, Andrich F, Fortes-Dias CL, Perales J, Teixeira-Ferreira A, Vassallo DV, et al. Molecular and biochemical characterization of a cytolysin from the Scorpaena plumieri (scorpionfish) venom: evidence of pore formation on erythrocyte cell membrane. Toxicon. 2013;74:92–100.View ArticlePubMedGoogle Scholar
- Gomes HL, Menezes TN, Malacarne PF, Roman-Campos D, Gondim AN, Cruz JS, et al. Cardiovascular effects of Sp-CTx, a cytolysin from the scorpionfish (Scorpaena plumieri) venom. Toxicon. 2016;118:141–8.View ArticlePubMedGoogle Scholar
- Evangelista KS, Andrich F, Figueiredo de Rezende F, Niland S, Cordeiro MN, Horlacher T, et al. Plumieribetin, a fish lectin homologous to mannose-binding B-type lectins, inhibits the collagen-binding alpha1beta1 integrin. J Biol Chem. 2009;284(50):34747–9.View ArticleGoogle Scholar
- Andrich F, Richardson M, Naumann GB, Cordeiro MN, Santos AV, Santos DM, et al. Identification of C-type isolectins in the venom of the scorpionfish Scorpaena plumieri. Toxicon. 2015;95:67–71.View ArticlePubMedGoogle Scholar
- Gomes HL, Menezes TN, Carnielli JBT, Andrich F, Evangelista KS, Chávez-Olórtegui C, et al. Stonefish antivenom neutralises the inflammatory and cardiovascular effects induced by scorpionfish Scorpaena plumieri venom. Toxicon. 2011;57(7–8):992–9.View ArticlePubMedGoogle Scholar
- Hopkins BJ, Hodgson WC. Cardiovascular studies on venom from the soldierfish (Gymnapistes marmoratus). Toxicon. 1998;36(7):973–83.View ArticlePubMedGoogle Scholar
- Sosa-Rosales JI, Piran-Soares AA, Farsky SH, Takehara HA, Lima C, Lopes-Ferreira M. Important biological activities induced by Thalassophryne maculosa fish venom. Toxicon. 2005;45(2):155–61.View ArticlePubMedGoogle Scholar
- Haddad Jr V, Neto DG, de Paula Neto JB, de Luna Marques FP, Barbaro KC. Freshwater stingrays: study of epidemiologic, clinic and therapeutic aspects based on 84 envenomings in humans and some enzymatic activities of the venom. Toxicon. 2004;43(3):287–94.View ArticlePubMedGoogle Scholar
- Garnier P, Grosclaude JM, Goudey-Perrière F, Gervat V, Gayral P, Jacquot C, et al. Presence of norepinephrine and other biogenic amines in stonefish venom. J Chromotogr B Biomed Appl. 1996;685(2):364–9.View ArticleGoogle Scholar
- Church JE, Hodgson WC. Dose-dependent cardiovascular and neuromuscular effects of stonefish (Synanceja trachynis) venom. Toxicon. 2000;38(3):391–407.View ArticlePubMedGoogle Scholar
- Hopkins BJ, Hodgson WC, Sutherland SK. An in vitro pharmacological examination of venom from the soldierfish Gymnapistes marmoratus. Toxicon. 1997;35(7):1101–11.View ArticlePubMedGoogle Scholar
- Cohen AS, Olek AJ. An extract of lionfish (Pterois volitans) spine tissue contains acetylcholine and a toxin that affects neuromuscular transmission. Toxicon. 1989;27(12):1367–76.View ArticlePubMedGoogle Scholar
- Rodrigues RJ. Pharmacology of south American freshwater stingray venom (Potamotrygon motoro). Trans N Y Acad Sci. 1972;34(8):677–86.View ArticlePubMedGoogle Scholar
- Khoo HE, Yuen R, Poh CH, Tan CH. Biological activities of Synanceja horrida (stonefish) venom. Nat Toxins. 1992;1(1):54–60.View ArticlePubMedGoogle Scholar
- Garnier P, Goudey-Perrière F, Breton P, Dewulf C, Petek F, Perrière C. Enzymatic properties of the stonefish (Synanceia verrucosa Bloch and Schneider, 1801) venom and purification of a lethal, hypotensive and cytolytic factor. Toxicon. 1995;33(2):143–55.View ArticlePubMedGoogle Scholar
- Gutiérrez JM, Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie. 2000;82(9–10):841–50.View ArticlePubMedGoogle Scholar
- Calvete JJ, Moreno-Murciano MP, Theakston RD, Kisiel DG, Marcinkiewicz C. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J. 2003;372(Pt 3):725–34.View ArticlePubMedPubMed CentralGoogle Scholar
- Poh CH, Yuen R, Chung MC, Khoo HE. Purification and partial characterization of hyaluronidase from stonefish (Synanceja horrida) venom. Comp Biochem Physiol B. 1992;101(1–2):159–63.PubMedGoogle Scholar
- Rádis-Baptista G. Integrins, cancer and snake toxins (mini-review). J Venom Anim Toxins incl Trop Dis. 2005;11(3):217–41.View ArticleGoogle Scholar
- Faiz MA, Falkous G, Harris JB, Mantle D. Comparison of protease and related enzyme activities in snake venoms. Comp Biochem Physiol B Biochem Mol Biol. 1996;113(1):199–204.View ArticlePubMedGoogle Scholar
- Borges MH, Figueiredo SG, Leprevost FV, De Lima ME, Cordeiro Mdo N, Diniz MR, et al. Venomous extract protein profile of Brazilian tarantula Grammostola iheringi: searching for potential biotechnological applications. J Proteomics. 2016;136:35–47.View ArticlePubMedGoogle Scholar
- Ghafari SM, Jamili S, Bagheri KP, Ardakani EM, Fatemi MR, Shahbazzadeh F, et al. The first report on some toxic effects of green scat, Scatophagus argus an Iranian Persian Gulf venomous fish. Toxicon. 2013;66:82–7.View ArticlePubMedGoogle Scholar
- McLane MA, Sanchez EE, Wong A, Paquette-Straub C, Perez JC. Disintegrins. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4(4):327–55.View ArticlePubMedGoogle Scholar
- Eble JA, Niland S, Dennes A, Schmidt-Hederich A, Bruckner P, Brunner G. Rhodocetin antagonizes stromal tumor invasion in vitro and other alpha2beta1 integrin-mediated cell functions. Matrix Biol. 2002;21(7):547–58.View ArticlePubMedGoogle Scholar
- Pilorget A, Conesa M, Sarray S, Michaud-Levesque J, Daoud S, Kim KS, et al. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibts angiogenesis both in vitro and in vivo. J Cell Physiol. 2007;211(2):307–15.View ArticlePubMedGoogle Scholar
- Sarray S, Delamarre E, Marvaldi J, El Ayeb M, Marrakchi N, Luis J. Lebectin and lebecetin, two C-type lectins from snake venom, inhibit alpha5beta1 and alphaV-containing integrins. Matrix Biol. 2007;26(4):306–13.View ArticlePubMedGoogle Scholar
- Church JE, Hodgson WC. Adrenergic and cholinergic activity contributes to the cardiovascular effects of lionfish (Pterois volitans) venom. Toxicon. 2002;40(6):1083–93.View ArticlePubMedGoogle Scholar
- Carlson RW, Schaeffer Jr RC, La Grance RG, Roberts CM, Russel FE. Some pharmacological properties of the venom of the scorpionfish Scorpaena guttata. Toxicon. 1971;9:379–91.View ArticlePubMedGoogle Scholar
- Magalhães GS, Lopes-Ferreira M, Junqueira-de-Azevedo IL, Spencer PJ, Araújo MS, Portaro FC, et al. Natterins, a new class of proteins with kininogenase activity characterized from Thalassophryne nattereri fish venom. Biochimie. 2005;87(8):687–99.View ArticlePubMedGoogle Scholar
- Komegae EN, Ramos AD, Oliveira AK, Serrano SM, Lopes-Ferreira M, Lima C. Insights into the local pathogenesis induced by fish toxins: role of natterins and nattectin in the disruption of cell-cell and cell-extracellular matrix interactions and modulation of cell migration. Toxicon. 2011;58(6–7):509–17.View ArticlePubMedGoogle Scholar
- Kilpatrick DC. Animal lectins: a historical introduction and overview. Biochim Biophys Acta. 2002;1572(2–3):187–97.View ArticlePubMedGoogle Scholar
- Khoo HE. Bioactive proteins from stonefish venom. Clin Exp Pharmacol Physiol. 2002;29(9):802–6.View ArticlePubMedGoogle Scholar
- Chen D, Kini RM, Yuen R, Khoo HE. Haemolytic activity of stonustoxin from stonefish (Synanceja horrida) venom: pore formation and the role of cationic amino acid residues. Biochem J. 1997;325(Pt 3):685–91.View ArticlePubMedPubMed CentralGoogle Scholar
- Ellisdon AM, Reboul CF, Panjikar S, Huynh K, Oellig CA, Winter KL, et al. Stonefish toxin defines an ancient branch of the perforin-like superfamily. Proc Natl Acad Sci U S A. 2015;112(50):15360–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Magalhães GS, Junqueira-de-Azevedo IL, Lopes-Ferreira M, Lorenzini DM, Ho PL, Moura-da-Silva AM. Transcriptome analysis of expressed sequence tags from the venom glands of the fish Thalassophryne nattereri. Biochimie. 2006;88(6):693–9.View ArticlePubMedGoogle Scholar
- Baumann K, Casewell NR, Ali SA, Jackson TN, Vetter I, Dobson JS, et al. A ray of venom: combined proteomic and transcriptomic investigation of fish venom composition using barb tissue from the blue-spotted stingray (Neotrygon kuhlii). J Proteomics. 2014;109:188–98.View ArticlePubMedGoogle Scholar
- Costa FLS, de Lima ME, Pimenta AC, Figueiredo SG, Kalapothakis E, Salas CE. Expressed sequence tags in venomous tissue of Scorpaena plumieri (Scorpaeniformes: Scorpaenidae). Neotrop Ichthyol. 2014;12(4):871–8.View ArticleGoogle Scholar
- Xie B, Li X, Lin Z, Ruan Z, Wang M, Liu J, et al. Prediction of toxin genes from Chinese yellow catfish based on transcriptomic and proteomic sequencing. Int J Mol Sci. 2016;17(4):E556.View ArticlePubMedGoogle Scholar
- White J. Antivenom Handbook. Melbourne: CSL Ltd; 1995. http://catalogue.nla.gov.au/Record/1478936.Google Scholar
- Church JE, Hodgson WC. Stonefish (Synanceia trachynis) antivenom: in vitro efficacy and clinical use. J Toxicol Toxin Rev. 2003;22(1):69–76.View ArticleGoogle Scholar
- Church JE, Hodgson WC. Stonefish (Synanceia spp.) antivenom neutralises the in vitro and in vivo cardiovascular activity of soldierfish (Gymnapistes marmoratus) venom. Toxicon. 2001;39(2–3):319–24.View ArticlePubMedGoogle Scholar
- Shiomi K, Hosaka M, Yamanaka H, Kikuchi T. Venoms from six species of marine fish: lethal and hemolytic activities and their neutralization by commercial stonefish antivenom. Mar Biol. 1989;103:285–89.View ArticleGoogle Scholar